Literature DB >> 30904715

Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review.

Jafar Karami1, Saeed Aslani2, Ahmadreza Jamshidi2, Masoud Garshasbi3, Mahdi Mahmoudi4.   

Abstract

Three important factors, including genetics, environment factors and autoimmunity play a role in the pathogenesis of rheumatoid arthritis (RA). The heritability of RA has been accounted to be 50-60%, while the HLA involvement in heritability of the disease has been accounted to be 10-40%. It has been documented that shared epitope (SE) alleles, such as HLA-DRB1*01 and DRB1*04, some HLA alleles like HLA-DRB1*13 and DRB1*15 are connected to RA susceptibility. An advanced classification of SE categorizes SE alleles into four main groups namely, S1, S2, S3D, and S3P. The S2 and S3P groups have been linked to susceptibility of seropositive RA. Various genome-wide association studies (GWAS) have discovered many susceptibility loci implicated in pathogenesis of RA. Some of the important single nucleotide polymorphisms (SNPs) linked to RA are TRAF1, STAT4, CTLA4, IRF5, CCR6, PTPN22, IL23R, and PADI4. HLA and non-HLA genes may discriminate anti-cyclic citrullinated peptide (anti-CCP) antibody-positive and anti-CCP-negative RA groups. Furthermore, risk of the disease has also been linked to environmental agents, mainly cigarette smoking. Pharmacogenomics has also confirmed SNPs or genetic patterns that might be linked to drugs responses. Different aspects of genetic involvement in the pathogenesis, etiology, and RA complications are reviewed in this article.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genetics; HLA shared epitope; Pathogenesis; Rheumatoid arthritis

Mesh:

Substances:

Year:  2019        PMID: 30904715     DOI: 10.1016/j.gene.2019.03.033

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  35 in total

Review 1.  Effect of vitamin E supplementation in rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Rui Zhang; Jianbing Ma; Haiyang Kou; Zhong Qing; Hao Guo
Journal:  Eur J Clin Nutr       Date:  2022-04-25       Impact factor: 4.016

2.  [Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis].

Authors:  X Lou; L Liao; X J Li; N Wang; S Liu; R M Cui; J Xu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

3.  Assessing improved risk prediction of rheumatoid arthritis by environmental, genetic, and metabolomic factors.

Authors:  Lilia Bouzit; Susan Malspeis; Jeffrey A Sparks; Jing Cui; Elizabeth W Karlson; Kazuki Yoshida; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2021-07-10       Impact factor: 5.431

Review 4.  Role of T Cells in the Pathogenesis of Rheumatoid Arthritis: Focus on Immunometabolism Dysfunctions.

Authors:  Maryam Masoumi; Samira Alesaeidi; Hossein Khorramdelazad; Mousa Behzadi; Rasoul Baharlou; Shahin Alizadeh-Fanalou; Jafar Karami
Journal:  Inflammation       Date:  2022-10-10       Impact factor: 4.657

Review 5.  Destructive Roles of Fibroblast-like Synoviocytes in Chronic Inflammation and Joint Damage in Rheumatoid Arthritis.

Authors:  Maryam Masoumi; Hamidreza Bashiri; Hossein Khorramdelazad; Khadijeh Barzaman; Nader Hashemi; Hale Abdoli Sereshki; Amirhossein Sahebkar; Jafar Karami
Journal:  Inflammation       Date:  2020-10-28       Impact factor: 4.092

Review 6.  Innate immunity drives pathogenesis of rheumatoid arthritis.

Authors:  Maria I Edilova; Ali Akram; Ali A Abdul-Sater
Journal:  Biomed J       Date:  2020-07-08       Impact factor: 4.910

7.  ZIP8 exacerbates collagen-induced arthritis by increasing pathogenic T cell responses.

Authors:  Jung-Ah Kang; Ji-Sun Kwak; Sang-Heon Park; Kyu-Young Sim; Seul Ki Kim; Youngnim Shin; In Jung Jung; Jeong-In Yang; Jang-Soo Chun; Sung-Gyoo Park
Journal:  Exp Mol Med       Date:  2021-04-01       Impact factor: 8.718

8.  Genetic Factors of Predisposition and Clinical Characteristics of Rheumatoid Arthritis in Russian Patients.

Authors:  Ekaterina A Vetchinkina; Dmitry S Mikhaylenko; Ekaterina B Kuznetsova; Tatiana A Deryagina; Ekaterina A Alekseeva; Irina V Bure; Andrey A Zamyatnin; Marina V Nemtsova
Journal:  J Pers Med       Date:  2021-05-25

9.  Risk of Toxicity After Initiating Immune Checkpoint Inhibitor Treatment in Patients With Rheumatoid Arthritis.

Authors:  Elizaveta Efuni; Samuel Cytryn; Patrick Boland; Timothy B Niewold; Anna Pavlick; Jeffrey Weber; Sabina Sandigursky
Journal:  J Clin Rheumatol       Date:  2021-10-01       Impact factor: 3.902

Review 10.  Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies.

Authors:  Mir Sohail Fazeli; Vadim Khaychuk; Keith Wittstock; Boris Breznen; Grace Crocket; Mir-Masoud Pourrahmat; Leticia Ferri
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.